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Inoculation of inﬂ  uenza (H5N1) into beagles resulted in 
virus excretion and rapid seroconversion with no disease. 
Binding studies that used labeled inﬂ  uenza (H5N1) showed 
virus attachment to higher and lower respiratory tract tis-
sues. Thus, dogs that are subclinically infected with inﬂ  u-
enza (H5N1) may contribute to virus spread.
A
vian inﬂ  uenza (H5N1) virus has been shown to be 
infectious not only for birds but also for humans 
and mammals such as mice, ferrets, and cats. Carnivo-
rous mammals that are susceptible to subtype H5N1 may 
contribute to spread of the virus; shedding of inﬂ  uenza 
(H5N1) by pet carnivores may pose a risk to humans. 
Cats experimentally inoculated with inﬂ  uenza  (H5N1) 
have been shown to be susceptible to infection and to shed 
virus (1). However, dogs’ susceptibility to this virus is 
unknown. Unpublished studies indicate that a substantial 
number of dogs tested in Thailand were positive for an-
tibodies against H5N1 subtype (2). Recently, isolation of 
inﬂ  uenza (H5N1) virus from a dog in Thailand has been 
reported (3). We describe the susceptibility of speciﬁ  c 
pathogen–free (SPF) beagles to avian inﬂ  uenza (H5N1) 
and the presence of receptors for inﬂ  uenza (H5N1) in the 
respiratory tract of these dogs.
The Study
To study the infectivity of avian inﬂ  uenza (H5N1) in 
dogs, we inoculated 3 SPF beagles (HsdCpb:DOBE; Har-
lan Nederland, Horst, the Netherlands), 16 weeks of age, 
with 106 median tissue culture infectious doses of inﬂ  u-
enza (H5N1) (A/chicken/GxLA/1204/2004). Half of the 
dose (0.5 mL) was administered intranasally and the other 
0.5mL intratracheally. Body temperature and health status 
of the dogs were monitored twice a day during the ﬁ  rst 5 
days after challenge and once a day thereafter. No major 
changes in body temperature and no clinical signs were 
noted. 
Excretion of virus was monitored daily in swabs from 
rectum, oropharynx, and nose. The presence of inﬂ  uenza 
(H5N1) virus in these swabs was studied by inoculation 
into embryonated eggs and by real-time reverse transcrip-
tion–PCR that targeted the matrix gene. For the PCR, we 
used the forward primer AI-M-F45 (5′-CTTCTAACC-
GAGGTCGAAACGTA-3′, reverse primer AI-M-R251 
(5′-CACTGGGCACGGTGAGC-3′) and Taqman probe 
AI-M-Tqmn1 (5′-6FAM-CTCAAAGCCGAGATCGCG-
CAGA-XT-PH) (TIBMolBiol, Berlin, Germany). A cali-
bration curve consisting of serial dilutions of a standard 
batch of inﬂ  uenza (H5N1) virus with a known median 50% 
egg infectious dose (EID50) titer was included in each PCR. 
One of the dogs shed virus for several days after challenge. 
In this dog, virus was demonstrated by PCR in nasal swabs 
taken on days 1 through 4 after challenge and by virus iso-
lation in embryonated chicken eggs on days 2 and 3 after 
challenge (Table 1). Quantiﬁ  cation by real-time PCR indi-
cated that the amount of virus present in the nasal swabs 
corresponded to 2.0–3.2 log10 EID50. 
Serum samples collected at days 7 and 14 after chal-
lenge were tested for antibodies against H5N1 subtype in 
an inﬂ  uenza A nucleoprotein-blocking ELISA as well as in 
a hemagglutination-inhibition assay. An antibody response 
against inﬂ  uenza (H5N1) was detectable in 1 dog at day 7 
after challenge. In all dogs an antibody response against 
inﬂ  uenza (H5N1) was demonstrated in both assays at day 
14 after challenge (Table 2). Postmortem examination on 
day 14 after virus challenge showed no gross pathologic or 
histopathologic changes in the respiratory tract and other 
organs. Considering the time of sampling after challenge, 
transient histopathologic changes may have occurred 
unnoticed.
Inﬂ  uenza (H5N1) viruses bind with their hemagglutinin 
surface proteins to cell surface oligosaccharides terminat-
ing in sialic acid α2,3 galactose (SA2,3Gal) (4). In humans 
and cats, inﬂ  uenza (H5N1) virus predominantly attaches to 
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Table 1. Virus detection in nasal swabs from dogs inoculated with avian influenza (H5N1)*  
Days postinoculation 
123 4
Dog PCR† Egg PCR Egg PCR Egg PCR Egg
11 0
3.2 –1 0
2.0 +1 0
2.9 +1 0
2.8 –
2– – – – – – – –
3– – – – – – – –
*PCR, real-time PCR of nasal swabs from dogs; Egg, embryonated chicken eggs.; + virus detected; –, virus not detected.  
†After quantification by PCR, virus titers are expressed as 50% egg infectious dose. Avian Inﬂ  uenza (H5N1), Dogs
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the lower part of the respiratory tract where the SA2,3Gal 
receptors are present (5). To study the attachment pattern of 
inﬂ  uenza (H5N1) in the respiratory tract of dogs, we per-
formed binding experiments with labeled inﬂ  uenza (H5N1) 
virus on formaldehyde-ﬁ  xed and parafﬁ  n-embedded tissue 
sections. We collected tissues directly from a euthanized 
control dog of the same breed as that used for the infection 
experiment and ﬁ  xed them in 4% buffered formaldehyde 
solution for several weeks. Virus labeling and histochemi-
cal examination were performed according to van Riel et 
al. (5). Brieﬂ  y, inﬂ  uenza (H5N1) virus was grown in 10-
day-old embryonated eggs and inactivated with formalin. 
After being puriﬁ  ed by sucrose gradient centrifugation, the 
virus was labeled with ﬂ  uorescein isothiocyanate (FITC). 
Staining was performed by incubating tissue sections with 
FITC-labeled virus and detecting the FITC-label with a per-
oxidase-labeled rabbit anti-FITC. To create a negative con-
trol, staining was performed without prior incubation with 
labeled virus or after prior incubation with FITC alone. No 
staining was observed in these negative controls. Chicken 
tissues were used as positive controls. 
Strong virus binding to the epithelia of the chicken re-
spiratory tract tissues was noted. Furthermore, as a speciﬁ  c-
ity control, preincubation with Maackia amurensis lectin, 
which speciﬁ  cally binds to SA2,3Gal–terminated oligosac-
charides, was performed. Moderate particulate binding of 
inﬂ  uenza (H5N1) to canine nasal mucosa, tracheal epithe-
lium, and alveoli was observed. Strong multifocal binding 
was observed in bronchial epithelium (Figure). This stain-
ing pattern was also found after binding of FITC-labeled 
M. amurensis lectin to canine respiratory tract tissues. Vi-
rus binding could be blocked with unlabeled M. amurensis 
lectin.
Conclusions
Our results demonstrate that dogs are susceptible to 
infection with avian inﬂ  uenza (H5N1) virus and can shed 
virus from the nose without showing apparent signs of dis-
ease. Moreover, receptors for avian (H5N1) virus are pres-
ent not only in the lower part of the respiratory tract of dogs 
but also in their trachea and nose, which are potential por-
tals of entry for the virus.
Inﬂ  uenza virus infection of dogs was ﬁ  rst reported in 
2004 (6). Inﬂ  uenza (H3N8) of equine origin caused out-
breaks in greyhounds in Florida and has since been found 
in dogs in >20 US states (7). The course of experimental 
infection of SPF dogs with subtype H5N1 resembles that of 
the experimental infection of dogs with the subtype H3N8 
(6): all dogs seroconverted, and some excreted virus without 
obvious disease. In contrast to the experimental outcomes, 
natural infections with inﬂ  uenza (H3N8) resulted in seri-
ous illness, death, and widespread infection for dogs. This 
ﬁ  nding warrants special attention to the potential course of 
avian inﬂ  uenza (H5N1) infection in dogs. Therefore, dogs’ 
contact with birds and poultry should be avoided in areas 
with inﬂ  uenza (H5N1) outbreaks to prevent possible spread 
of virus and human exposure to inﬂ  uenza (H5N1) virus that 
might have been adapted to mammals.
The Dutch Ministry of Agriculture ﬁ  nancially supported this 
study.
Table 2. Antibody titers in serum of dogs inoculated with avian influenza (H5N1)* 
Days postinoculation 
07 1 4
Dog ELISA HI† ELISA HI† ELISA HI†
1– – – – + 1 6
2– – – – + 1 6
3– – + 1 6 + 3 2
*Antibodies were measured in a nucleoprotein-blocking ELISA and in the hemagluttination-inhibition (HI) assay at different days postinoculation. +, 
antibodies detected; –, antibodies not detected. 
†HI titers are presented as the reciprocal to the highest serum dilutions completely inhibiting agglutination of chicken erythrocytes by influenza (H5N1) 
virus. 
Figure. Binding of ﬂ   uorescein isothiocyanate–labeled inﬂ  uenza 
(H5N1) virus to formaldehyde-ﬁ  xed,  parafﬁ  n-embedded  tissue 
slides of dog respiratory tract tissues. Left panel shows binding 
of virus (arrow). Right panel shows blocking of virus binding by 
competitive binding of Maackia amurensis lectin to sialic acid α2,3 
galactose.